Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-19-016964
Filing Date
2019-08-30
Accepted
2019-08-29 21:50:38
Documents
12
Period of Report
2019-07-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A f8k072319a1_nektarthera.htm   iXBRL 8-K/A 23445
  Complete submission text file 0001213900-19-016964.txt   197124

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nktr-20190630.xsd EX-101.SCH 3171
3 XBRL LABEL FILE nktr-20190630_lab.xml EX-101.LAB 33466
4 XBRL PRESENTATION FILE nktr-20190630_pre.xml EX-101.PRE 21945
9 EXTRACTED XBRL INSTANCE DOCUMENT f8k072319a1_nektarthera_htm.xml XML 4093
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-24006 | Film No.: 191067758
SIC: 2834 Pharmaceutical Preparations